About
Science for industryPress
Participants
Knowledge-generating bodiesStartupsCompaniesInvestors
Summit
SpeakersAgenda
Past Editions
S4i 2024S4i 2025
Catalogues
PatentsPrototypesChallenges
About
Science for industryPress
Participants
Knowledge-generating bodiesStartupsCompaniesInvestors
Summit
AgendaSpeakersTickets
Past Editions
S4i 2024S4i 2025
Catalogues
PatentsPrototypesChallenges
Get your tickets
Science for Industry
La Nave Madrid
C. Cifuentes, 5, 28021, Madridmarketing@s4industry.eu

COMPOSITION COMPRISING VANCOMYCIN AND ORLISTAT

Patent number:

EP3237011B1

Bélgica.svg
No items found.

The present invention relates to novel combinations of substances and novel pharmaceutical compositions for treating mycobacterial infections, and medical uses of those combinations and compositions. The present invention further concerns a method for screening new compounds useful for treating mycobacterial infections and multidrug resistant (MDR) and Extremely resistant (XDR) mycobacterial strains.

Countries:
Belgium
Regions:
No items found.
Centers:
UNIVERSITE LIBRE DE BRUXELLES
Other entities:
Sectors:
Health
Subsectors:
TRL Level:
TRL 3 – experimental proof of concept
BRL Level:
PDF Link:
Download here
Video Link:
Watch it here
Sustainable Development Goal:
SDG03: Good health and well-being
Applications

Key advantages of the technology New strategies against all mycobacteria including MDR and XDR-TB ; Successful in vitro antimycobacterial activity.

Comments

Other related patents

Health
New & Sustainable Materials

SURFACTANT-BASED HYDROGEL, METHODS AND USES THEREOF

Countries
Portugal
Know more
Health

New therapeutic target for the treatment of myotonic dystrophy

Countries
Spain
Know more
Health

SARS-CoV-2 peptides and proteins with reduced adherence to Angiotensin Converting Enzyme-2

Countries
Spain
Know more
Get back to patents directory